Assignee

Cerulean Pharma Inc.

Patents = 21

Forward Citations = 170

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

20 inventors (with patents filed for the assignee):

Cerulean Pharma Inc. is a pharmaceutical company focused on developing innovative nanotechnology-based therapies for the treatment of various cancers. Their proprietary nanoparticle-drug conjugate (NDC) technology enables the precise delivery of potent anti-cancer drugs directly to tumors, enhancing their efficacy while reducing systemic toxicity. With a mission to improve patients' lives, Cerulean Pharma Inc. is committed to advancing the field of oncology through groundbreaking research and development.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com